论文部分内容阅读
目的:观察中药离子导入联合顺铂腹腔注射治疗癌性腹水的临床疗效。方法:将60例卵巢癌并腹腔积液患者根据患者意愿分为治疗组和对照组,对照组应用顺铂腹腔注射治疗,治疗组应用中药离子导入联合顺铂腹腔注射治疗,比较两组临床疗效、症状改善情况以及血清CA125水平。结果:治疗组总疗效、症状好转率以及血清CA125水平均优于对照组,两组比较,差异有统计学意义(P<0.05)。结论:中药离子导入联合顺铂腹腔注射治疗癌性腹水临床疗效显著,对于改善患者生存质量意义重大。
Objective: To observe the clinical efficacy of iontophoresis combined with cisplatin intraperitoneal injection in the treatment of cancerous ascites. Methods: Sixty patients with ovarian cancer and ascitic fluid were divided into treatment group and control group according to patients’ wishes. The control group was treated with intraperitoneal injection of cisplatin. The treatment group was treated with iontophoresis plus cisplatin by intraperitoneal injection. The clinical curative effect , Symptom improvement and serum CA125 levels. Results: The total curative effect, symptom improvement rate and serum CA125 level in the treatment group were better than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: The Chinese medicine iontophoresis combined with cisplatin intraperitoneal injection of cancerous ascites clinical efficacy is significant, for improving the quality of life of patients with great significance.